10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q2 2021

Filing Information

Form Type	10-Q
Accession Number	`0001179929-21-000134`
Period End Date	20210630
Filing Date	20210729
Fiscal Year	2021
Fiscal Period	Q2
XBRL Instance	moh-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 90 Cash Flow Statement 68 Stockholders Equity 39 Comprehensive Income 24

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.30B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	59.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.61B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.15B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	58.00M	shares	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.24B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.88B	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.86B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.67B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$168.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$175.00M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.87B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.88B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$383.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$391.00M	USD	Point-in-time
Goodwill, and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$941.00M	USD	Point-in-time
Goodwill, and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$929.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$136.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$145.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$69.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$65.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$134.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$119.00M	USD	Point-in-time
Total assets	`Assets`	$9.53B	USD	Point-in-time
Total assets	`Assets`	$10.53B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.94B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.85B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.70B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$2.07B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$1.25B	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$641.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$651.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$42.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$375.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.71B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.96B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.13B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$2.13B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$225.00M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$223.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$101.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$119.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.16B	USD	Point-in-time
Total liabilities	`Liabilities`	$7.44B	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at June 30, 2021, and 59 million shares at December 31, 2020	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at June 30, 2021, and 59 million shares at December 31, 2020	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$199.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$191.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$26.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$37.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.86B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$2.15B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.37B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.10B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$10.53B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$9.53B	USD	Point-in-time

Income Statement 90 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`PremiumsEarnedNet`	$8.68B	USD	2 Qtrs
Premium revenue	`PremiumsEarnedNet`	$6.58B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$4.37B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$12.89B	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$372.00M	USD	2 Qtrs
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$157.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$185.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$307.00M	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$71.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$137.00M	USD	2 Qtrs
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$38.00M	USD	2 Qtrs
Investment income	`NetInvestmentIncome`	$13.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$19.00M	USD	2 Qtrs
Investment income	`NetInvestmentIncome`	$10.00M	USD	1 Quarter
Other revenue	`InterestAndDividendIncomeOperating`	$9.00M	USD	2 Qtrs
Other revenue	`InterestAndDividendIncomeOperating`	$5.00M	USD	1 Quarter
Other revenue	`InterestAndDividendIncomeOperating`	$22.00M	USD	1 Quarter
Other revenue	`InterestAndDividendIncomeOperating`	$42.00M	USD	2 Qtrs
Total revenue	`Revenues`	$6.80B	USD	1 Quarter
Total revenue	`Revenues`	$9.17B	USD	2 Qtrs
Total revenue	`Revenues`	$4.62B	USD	1 Quarter
Total revenue	`Revenues`	$13.32B	USD	2 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$7.31B	USD	2 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$11.29B	USD	2 Qtrs
Medical care costs	`CostOfGoodsAndServicesSold`	$5.82B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$3.60B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$662.00M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$345.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$957.00M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$484.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$185.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$372.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$307.00M	USD	2 Qtrs
Premium tax expenses	`PremiumTaxExpenses`	$157.00M	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$139.00M	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	2 Qtrs
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$71.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$31.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$21.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$64.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$41.00M	USD	2 Qtrs
Other	`OtherCostAndExpenseOperating`	$8.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$2.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$28.00M	USD	2 Qtrs
Other	`OtherCostAndExpenseOperating`	$6.00M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$6.53B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$12.71B	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.19B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$8.47B	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$424.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$698.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$608.00M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$273.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$30.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$24.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$60.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$45.00M	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Other expense, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	1 Quarter
Other expense, net	`OtherNonoperatingIncomeExpense`	$-5.00M	USD	2 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-30.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-50.00M	USD	2 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-60.00M	USD	2 Qtrs
Total other expenses, net	`NonoperatingIncomeExpense`	$-29.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$243.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$548.00M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$648.00M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$395.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$135.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$194.00M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$119.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$58.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$413.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$7.65	USD	2 Qtrs
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$4.72	USD	1 Quarter
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$3.20	USD	1 Quarter
Net income per share - Basic (in dollars per share)	`EarningsPerShareBasic`	$7.14	USD	2 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.05	USD	2 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$7.54	USD	2 Qtrs
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.16	USD	1 Quarter
Net income per share - Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.65	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$413.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$64.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$41.00M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-7.00M	USD	2 Qtrs
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-6.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$28.00M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$35.00M	USD	2 Qtrs
Loss on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	$-5.00M	USD	2 Qtrs
Loss on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$10.00M	USD	2 Qtrs
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-1.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$192.00M	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$174.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$157.00M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$106.00M	USD	2 Qtrs
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$272.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$792.00M	USD	2 Qtrs
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$201.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-15.00M	USD	2 Qtrs
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$259.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-195.00M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-333.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$14.00M	USD	2 Qtrs
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$184.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.06B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$757.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$670.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.01B	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$750.00M	USD	2 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$622.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$29.00M	USD	2 Qtrs
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$45.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-3.00M	USD	2 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-5.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$38.00M	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-408.00M	USD	2 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$128.00M	USD	2 Qtrs
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$453.00M	USD	2 Qtrs
Common stock withheld to settle employee tax obligations	`CommonStockWithheldToSettleEmployeeTaxObligations`	$52.00M	USD	2 Qtrs
Common stock withheld to settle employee tax obligations	`CommonStockWithheldToSettleEmployeeTaxObligations`	$8.00M	USD	2 Qtrs
Contingent consideration liabilities settled	`PaymentForContingentConsiderationLiabilityFinancingActivities`	-	USD	2 Qtrs
Contingent consideration liabilities settled	`PaymentForContingentConsiderationLiabilityFinancingActivities`	$20.00M	USD	2 Qtrs
Proceeds from senior notes offering, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$789.00M	USD	2 Qtrs
Proceeds from senior notes offering, net of issuance costs	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	2 Qtrs
Repayment of term loan facility	`RepaymentsOfLinesOfCredit`	$600.00M	USD	2 Qtrs
Repayment of term loan facility	`RepaymentsOfLinesOfCredit`	-	USD	2 Qtrs
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	-	USD	2 Qtrs
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$380.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-45.00M	USD	2 Qtrs
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$63.00M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-200.00M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$453.00M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$858.00M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.68B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.68B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.22B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time

Stockholders Equity 39 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	57.70M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	58.00M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	58.60M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.16B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.37B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.00B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.10B	USD	Point-in-time
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$413.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$122.00M	USD	1 Quarter
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$446.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-30.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	2 Qtrs
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$28.00M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$26.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$-27.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$21.00M	USD	1 Quarter
Ending Balance (in shares)	`SharesOutstanding`	57.70M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	58.00M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	58.60M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.00B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.16B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.37B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.10B	USD	Point-in-time

Comprehensive Income 24 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$228.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$454.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$413.00M	USD	2 Qtrs
Net income	`NetIncomeLoss`	$185.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$276.00M	USD	1 Quarter
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$37.00M	USD	2 Qtrs
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-14.00M	USD	2 Qtrs
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$1.00M	USD	1 Quarter
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$62.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-3.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$9.00M	USD	2 Qtrs
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$15.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$1.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-11.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$28.00M	USD	2 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$47.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$482.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$185.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$402.00M	USD	2 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$323.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.